Population-based colorectal cancer (CRC) screening has been shown to reduce incidence of colon cancer and related mortality [1, 2] . Among patients at average risk, the most favored cancer prevention test is colonoscopy every 10 years, beginning at age 50 (45 for African-Americans) [3] . Screening per 1000 patients using colonoscopy, a gain of 270 life-years and a decrease in 24 deaths from CRC has been estimated [4] .
Cap-assisted colonoscopy (CC) has been extensively studied as a modality to improve ADR. The cap is a straightforward attachment on the distal end of the endoscope that extends outward beyond the tip of tje colonoscope to varying lengths. The cap helps in deflecting and flattening the mucosal folds, and by keeping the mucosa away from the lens prevents a red-out. These maneuvers expose the proximal aspects of colonic folds and thereby help in detecting polyps in these otherwise blind mucosal areas. Use of cap has been shown to decrease cecal intubation time, increase cecal intubation rate and improve polyp detection rate. However, data on ADR are rather conflicting. The aim of this meta-analysis was to compare the performance of CC with standard colonoscopy (SC) for ADR among highquality randomized controlled trials (RCT).
Patients and methods

Search strategy
An electronic search was performed in MEDLINE, EMBASE, Google scholar, Cochrane database and Web of science. The search for studies of relevance was performed using the following key words and corresponding Medical Subject Heading/Entree terms when possible: "CAP assisted colonoscopy," "colonoscopy with distal attachment," "adenoma detection rate," "adenoma per person," "cecal intubation rate," "cecal intubation time" with varying combinations with and/or. We retrieved 2558 abstracts (▶ Fig. 1 ). Abstracts published in major international conferences, including Digestive Disease Week, United European Gastroenterology Week and Asia Pacific Digestive Week over the past 10 years were manually searched. References from major trials and review articles were manually searched.
From the 2400 records, 2358 records were removed (1473 studies, 927 abstracts) because they were not relevant to the comparison between CC and SC. Of the remaining 42 records, 23 were excluded for the following reasons: duplicity, case report, review article, editorial, abstract only. Of the 19 full-text articles that were accepted, only 7 met the criteria of prospective RCTs, Jadad score ≥3 (see ▶ Table 1 ), reported ADR, and these studies were used for ADR and APP (adenomas detected per person) [14 -20] . Of the 42 records, 17 studies were included that compared cecal intubation rate between CC and SC [14 -30] . Thirteen studies were included that compared cecal intubation time between CC and SC [14 -17, 19, 21 -23, 25, 26, 30 -32] . For analysis of cecal intubation and cecal intubation time, even studies with Jadad score < 3 were included. ADR alone was the primary aim of the study. We removed the constraints for cecal intubation time or rate as we wanted to be less stringent and more inclusive for these endpoints. While ADR is a cornerstone quality indicator for colonoscopy, the other two are not. and studies of cap-assisted colonoscopy identified for inclusion in the meta-analysis of adenoma detection rate.
▶ Table 1 Studies and their respective Jadad scores. 
Study
Data extraction
Two investigators (VN and MD) independently reviewed the studies and imported the data into a standardized form. In case of lack of consensus, the senior investigator (AR) reviewed the study independently and then made a final decision regarding the data point. Data extracted were patient demographics, year of publication, study location, number of subjects, size of adenomas, number of adenomas detected, cecal intubation rate, cecal intubation time and study quality. Individual study and patient characteristics are shown in ▶ Table 2 .
Statistical analysis
Meta-analyses were performed using Mantel-Haenszel method combining the results from different trials comparing CC and SC. Meta-Analysis was performed according to the PRISMA statement. A complete checklist is provided in ▶ Table 3 [33] . A random effects model was used for statistical heterogeneity across trials and a fixed effect model was used if no significant heterogeneity was present. Relative risks (RR) with corresponding 95 % CI were calculated. Heterogeneity was calculated using I 2 test. Publication bias was assessed using a funnel plot. Statistical analyses were performed using RevMan software (Review Manager version 5.3; The Nordic Cochrane Centre, Copenhagen, Demark, The Cochrane Collaboration 2015).
Results
Adenoma detection rate
An initial pooled analysis of eight RCTs (5681 patients) was performed, which showed a numerically higher ADR in the CC group compared to the SC group, but results were not statistically significant (OR 1.08, 95 % CI 0.97 -1.21; I 2 56 %) (▶ Fig.   2a ). However, when only high-quality RCTs were included (Jadad score ≥ 3) as per the primary aim of this study, there were seven RCTs with a total of 4,681 patients (2,344 patients in the CC group, 2,337 patients in the SC group). We were unbale to include some studies with a score of 3 or more, as they lacked information regarding ADR/APP [22, 24, 30] . ADR was significantly higher in the CC group (OR 1.18, 95 % CI 1.03 -1.33) (▶ Fig. 2b ). There was no significant heterogeneity in the ADR analysis (I 2 = 0 %). Publication bias for studies included for ADR was assessed using a funnel plot (▶ Fig. 3 ). Analysis was also performed using a random effects model. Analysis of the seven high-quality RCTs using the random effects model showed significantly higher ADR in the CC group (OR 1.104, 95 % CI 1.02 -1.18) (▶ Fig. 2c ).
Sensitivity analysis was not performed based on our stringent criteria to include only high-quality studies with Jadad score ≥ 3 which carry a very low risk for bias [34 -36] . Fig. 4 ). Significant heterogeneity was found in the studies reporting mean APP (I 2 = 68 %).
▶
Large adenoma detection rate
Analysis for large adenomas ( ≥ 10 mm) included four RCTs with 2468 patients. There were 1247 patients in the CC group compared to 1221 patients in the SC group. Use of cap led to a statistically significantly higher rate of detection of large adenomas (OR 1.49, 95 % CI 1.03 -2.15, P < 0.005) with heterogeneity of (I 2 = 44 %) (▶ Fig. 5 ).
Sessile serrated adenoma detection rate
Analysis for sessile serrated adenoma (SSA) included only three RCTs with 2872 patients. There were 1427 patients in the CC group compared to 1445 patients in the SC group. Use of cap did not lead to any significant difference in detection of SSA with (OR 1.12, 95 % CI 0.66 -1.88) and a significant heterogeneity of (I 2 = 76 %) (▶ Fig. 6 ).
Cecal intubation rate and time
Pooled analysis of 17 studies that included 5416 patients in the CC and 5401 patients in the SC groups were utilized to evaluate the cecal intubation rate (▶ Fig. 7a ). The cecal intubation rate in the CC group was 96.3 % compared to 94.5 % with SC. Use of cap improved cecal intubation (OR 1.61, 95 % CI 1.33 -1.95) when compared to SC (P < 0.001). Low heterogeneity was identified among studies (I 2 = 2 %).
Thirteen studies were used to analyze the impact of cap on cecal intubation time (▶ Fig. 7b ). The CC group included 3014 patients and the SC group included 3037 patients. Use of cap decreased the cecal intubation time by an average of 0.88 minutes (95 % CI 0.37 -1.39) or 53 seconds. However, significant heterogeneity was detected among these studies (I 2 = 87 %).
Discussion
Results of our meta-analysis indicate that use of cap improves detection of adenomas. An improvement in ADR, mean number of adenomas detected per patient and large adenomas was seen with CC. For ADR we included only trials with a Jadad score ≥ 3 to ensure only high-quality trials. The Jadad score is the most widely used scale to measure the quality of RCTs. Overall, we found seven RCTs with a Jadad score ≥ 3. This study differs from a previous meta-analysis [13] in that we excluded the study by Lee [25] as it employed suboptimal techniques for randomization. Proper technique includes a statistician and computer-generated randomization, where as in the study by Lee et al, only sealed envelopes were used without mention of statistician or a computer-generated sequence [25] . Furthermore, in that study, the quality of bowel preparation was significantly less satisfactory. They classified the quality of their bowel preparation into three categories: "excellent," "fair," and "poor." In the results, they noted that a higher proportion of patients in the CC group had less satisfactory bowel preparation (excellent/fair/poor bowel preparation in CC group were 52.7:33.5:13.8 % vs. SC group's 62.3:28.1:9.6 %, respectively, P = 0.006). They also reported an ADR that was lower with use of CAP. The inferior bowel preparation in the CC group could have negatively impacted the ADR. As a matter of fact, this is the only trial where use of CAP has been associated with lower ADR compared to standard colonoscopy. All other trials have shown either no difference or higher ADR with CAP. ADR is a quality indicator for colonoscopy and has been shown to be associated with improved outcomes related to interval cancer and colorectal cancer-related mortality. While this meta-analysis shows an overall improvement in ADR with CC, individual studies have shown variable results. The study CAP showed an improvement in ADR. We have also shown an improvement in the average number of adenomas detected per patient.
CC also improved detection of large adenomas, however, a statistically significant improvement in mean number of diminutive adenomas was not found. We suspect this may be due, in part, to the differing sizes of small adenomas reported (5 mm vs. 6 mm). There was no significant improvement in detection of proximal adenomas or SSAs as the RCTs that were performed were not adequately powered to detect any difference in the above outcomes.
Our meta-analysis has some limitations. The study populations in the studies were very diverse with studies being performed in Asia, North America, and Europe. That, however, improves generalizability of the results. Given the obvious lack of blinding of the endoscopists and the nature of such studies evaluating devices to improve ADR, investigator bias is unavoidable. Endoscopist experience in the different studies also varies widely and could not be accounted for with respect to Use of a cap with colonoscopy requires some training, adjustment, and experience. This factor was not adjusted for or studied in the trials, making it difficult to gauge the impact of that on the results.
A cap is a simple, inexpensive and easy-to-use tool to improve the quality of colonoscopy. The cost of the cap, albeit low, appears to be the only negative factor weighing against its use in daily clinical practice. To derive maximum benefit from cap, endoscopists need to gain experience with the device. As the cap projects outside the tip of the colonoscope, it may appear to limit the angle of view. This must be compensated for withi adequate deflection of the tip and use of the edge of the cap to flatten the haustral folds to expose their proximal aspects and derive the maximum benefit. Furthermore, the benefit of CC has been shown to significantly extend visualization of the right colon in a colonoscopic training model [37] . Use of cap offers other secondary benefits such as improved cecal intubation rates and stabilization of the tip of the scope during polypectomy.
Conclusion
In conclusion, this meta-analysis showed that there is a marginal and statistically significant benefit to use of a cap during colonoscopy to improve ADR and cecal intubation rate and reduce cecal intubation time. Further research needs to be conducted to determine if there are specific patient subgroups that may benefit more from use of a cap, whether to train endoscopists in use of the device, and identify appropriate training methods. 
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